ANTI-HBC IGG ANTIBODY POSITIVE

ANTI-HBC IGG ANTIBODY POSITIVE was reported 36 times

ANTI-HBC IGG ANTIBODY POSITIVE is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Human Immunoglobulin G [EPC] 3 0.0001
1 Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 5 0.0001
2 Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 2 0.0001
3 General Anesthetic [EPC] 3 0.0001
4 Thrombopoietin Receptor Agonist [EPC] 1 0.0001
5 Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 6 0.0001
6 Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 1 0.0000
7 Antimycobacterial [EPC] 1 0.0000
8 Rifamycin Antibacterial [EPC] 1 0.0000
9 Nucleoside Analog Antiviral [EPC] 1 0.0000
10 Dihydrofolate Reductase Inhibitor Antibacterial [EPC] 1 0.0000
11 Purine Antimetabolite [EPC] 1 0.0000
12 Expectorant [EPC] 2 0.0000
13 Antirheumatic Agent [EPC] 1 0.0000
14 Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 1 0.0000
15 Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 1 0.0000
16 HMG-CoA Reductase Inhibitor [EPC] 3 0.0000
17 Calcineurin Inhibitor Immunosuppressant [EPC] 1 0.0000
18 Estrogen [EPC] 1 0.0000
19 CD20-directed Cytolytic Antibody [EPC] 1 0.0000
20 Corticosteroid [EPC] 3 0.0000
21 Folate Analog Metabolic Inhibitor [EPC] 1 0.0000
22 Tumor Necrosis Factor Blocker [EPC] 2 0.0000
23 Platelet Aggregation Inhibitor [EPC] 1 0.0000
24 Proton Pump Inhibitor [EPC] 1 0.0000
25 Benzodiazepine [EPC] 1 0.0000
26 Nonsteroidal Anti-inflammatory Drug [EPC] 1 0.0000